PCA Global Ventures, a global leader in compassionate customer care and specialized debt recovery collection solutions, today ...

The city council will vote on the bill in its meeting on March 9.

The University of Texas Permian Basin is inviting veterans to train as discussion leaders for the next cohort of its Mending ...

Atlassian now runs nearly one AI agent per employee. I met with SVP Tal Saraf to discuss what's working, who's building them, ...

Comprehensive Industry Onboarding SupplySide Fresh is a complete B2B industry onboarding solution, in partnership with ...

Whether you've ridden RAGBRAI every year or want to join for the first time, you're invited to learn more at "RAGBRAI for ...

Milwaukee Brewers pitcher Logan Henderson wants to get back to a healthy state of body and mind for the upcoming 2026 MLB ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...

About Path2 Hydrogen AG Path2 Hydrogen AG (FRA:PTHH.DE), formerly known as Philomaxcap AG, is a management holding company ...

OpenAI launches “Frontier Alliances” to help enterprises embed AI agents into core workflows and scale adoption beyond pilot ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics Olga Anczukow, Ph.D. Olga Anczukow, Ph.D.